Common Contracts

2 similar Retention Bonus Agreement contracts by ARCA Biopharma, Inc.

ARCA BIOPHARMA, INC. SECOND AMENDMENT TO RETENTION BONUS LETTER
Retention Bonus Agreement • April 23rd, 2024 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances • Colorado

This second amendment (this “Amendment”) is entered into effective as of April 22, 2024 by and between Thomas A. Keuer (“Executive”) and ARCA biopharma, Inc. (the “Company,” and together with Executive, the “Parties”).

ARCA BIOPHARMA, INC. SECOND AMENDMENT TO RETENTION BONUS LETTER
Retention Bonus Agreement • April 23rd, 2024 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances • Colorado

This second amendment (this “Amendment”) is entered into effective as of April 22, 2024 by and between C. Jeffrey Dekker (“Executive”) and ARCA biopharma, Inc. (the “Company,” and together with Executive, the “Parties”).